Mycophenolate mofetil and Wound dehiscence for Men aged 60+ (a phase IV clinical study of FDA data)

Summary:

Wound dehiscence is found for men aged 60+ who take Mycophenolate mofetil (mycophenolate mofetil). This study is created by eHealthMe based on reports of 11,580 men aged 60+ from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Mycophenolate mofetil when people have Wound dehiscence
Top conditions
Top co-used drugs
Top other side effects

On Jul, 05, 2026

11,580 men aged 60+ reported to have side effects when taking Mycophenolate mofetil.
Among them, 34 people (0.29%) have Wound dehiscence

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Wound dehiscence?

Wound dehiscence (a surgical incision reopens either internally or externally) is found to be associated with 659 drugs and 673 conditions by eHealthMe. Check the latest studies of Wound dehiscence.

Number of reports submitted per year:

Could Mycophenolate mofetil cause Wound dehiscence in men aged 60+?

Time on Mycophenolate mofetil when people have Wound dehiscence *

Severity of Wound dehiscence

n/a

How people recovered from Wound dehiscence

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Tuberculosis Of Central Nervous System (a bacterial infection of brain and spinal cord by mycobacterium tuberculosis): 10 people, 29.41%
Infection: 4 people, 11.76%
Immunodeficiency Disorders: 3 people, 8.82%
Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 1 person, 2.94%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Infection: 15 people, 44.12%
Tuberculosis Of Central Nervous System (a bacterial infection of brain and spinal cord by mycobacterium tuberculosis): 15 people, 44.12%
Fistula (an abnormal connection or passageway between two): 15 people, 44.12%
Paradoxical Drug Reaction: 15 people, 44.12%
Mycobacterium Abscessus Infection (rapid growing bacterial infection): 11 people, 32.35%
Gait Disturbance: 11 people, 32.35%
Mycobacterial Infection: 7 people, 20.59%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 17.65%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 5 people, 14.71%
Osteolysis (dissolution of bone): 5 people, 14.71%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Wound dehiscence?

- Check whether Wound dehiscence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Mycophenolate mofetil and Wound dehiscence

How the study uses the data?

The study is based on (applicable) gender, age, mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.